This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Leukaemia
  • /
  • Safety and efficacy of bosutinib in fourth-line th...

Safety and efficacy of bosutinib in fourth-line therapy of chronic myeloid leukemia patients.

Read time: 1 mins
Published:1st Feb 2019
Author: García-Gutiérrez V, Milojkovic D, Hernandez-Boluda JC, Claudiani S, Martin Mateos ML, Casado-Montero LF et al.
Availability: Pay for access, or by subscription
Ref.:Ann Hematol. 2019;98(2):321-330.
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest